Replimune

FDA
Pharma

Replimune secures FDA approval after long regulatory battle

The accelerated approval does not mean Replimune’s fate has completely reversed, as the company is still required to provide confirmatory data.
Angus Liu Aug 6, 2026 4:41pm
hiring new hire appointment executive

Bicara Therapeutics hires Replimune, Sanofi alum as CCO

May 12, 2026 7:24am
reducing people on team
Favicon Fierce Biotech

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am
dart board miss failure
Favicon Fierce Biotech

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm
FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm